Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2Carcinoma 2Salivary Gland Neoplasms 1Myelodysplastic Syndromes 1Lung Neoplasms 1Hemangioma, Cavernous, Central Nervous System 1Head and Neck Neoplasms 1Cytopenia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cyclophosphamide 39fludarabine phosphate 36Azacitidine 32fludarabine 24Whole-Body Irradiation 22Busulfan 22Tacrolimus 21Antilymphocyte Serum 21Mycophenolic Acid 19Filgrastim 17Methotrexate 16Melphalan 15Peripheral Blood Stem Cell Transplantation 13venetoclax 12thymoglobulin 12Granulocyte Colony-Stimulating Factor 12Cytarabine 12Cyclosporine 12Thiotepa 9Cord Blood Stem Cell Transplantation 9Alemtuzumab 8Rituximab 7Radiotherapy 7Methylprednisolone 7Decitabine 7Clofarabine 7Lenalidomide 6Stem Cell Transplantation 5Sirolimus 5Nivolumab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Myelodysplastic Syndromes × DNA × Clear all
NCT05148234 2025-09-30

BMS-986253 in Myelodysplastic Syndromes

National Institutes of Health Clinical Center (CC)

Phase 1/2 Terminated
2 enrolled 11 charts
Classical hematologyMyeloid

Cytopenia, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡